RVNC
First Trust Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-82,845
| Closed | -$950K | – | 2453 |
|
|
2023
Q3 | $950K | Sell |
82,845
-26,071
| -24% | -$299K | ﹤0.01% | 1981 |
|
|
2023
Q2 | $2.76M | Buy |
+108,916
| New | +$2.76M | ﹤0.01% | 1550 |
|
|
2022
Q2 | – | Sell |
-24,653
| Closed | -$481K | – | 2630 |
|
|
2022
Q1 | $481K | Sell |
24,653
-33,082
| -57% | -$645K | ﹤0.01% | 2265 |
|
|
2021
Q4 | $942K | Buy |
57,735
+2,191
| +4% | +$35.7K | ﹤0.01% | 2087 |
|
|
2021
Q3 | $1.55M | Buy |
55,544
+35,210
| +173% | +$981K | ﹤0.01% | 1868 |
|
|
2021
Q2 | $603K | Sell |
20,334
-52,682
| -72% | -$1.56M | ﹤0.01% | 2221 |
|
|
2021
Q1 | $2.04M | Buy |
73,016
+39,682
| +119% | +$1.11M | ﹤0.01% | 1718 |
|
|
2020
Q4 | $945K | Sell |
33,334
-22,451
| -40% | -$636K | ﹤0.01% | 1915 |
|
|
2020
Q3 | $1.4M | Sell |
55,785
-3,233
| -5% | -$81.3K | ﹤0.01% | 1576 |
|
|
2020
Q2 | $1.44M | Buy |
+59,018
| New | +$1.44M | ﹤0.01% | 1548 |
|
|
2019
Q2 | – | Sell |
-18,371
| Closed | -$290K | – | 2521 |
|
|
2019
Q1 | $290K | Buy |
+18,371
| New | +$290K | ﹤0.01% | 2279 |
|